Middleby
MIDD Nasdaq Industrial Machinery & Supplies & Components Financials FY2016βFY2025
Middleby's revenue rose 1.6% to $3.2 billion in fiscal 2025. Its operating margin was 18.0%, down from 20.4% a year earlier. Free cash flow was $559 million, down 13.9%. It paid out $724 million in dividends and buybacks, 129% of free cash flow. The diluted share count fell 3.7%.
What Middleby does
No business description yet.
- Legal name
- THE MIDDLEBY CORPORATION
- Fiscal year ends
- January 3, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0000769520-26-000011
0000769520
Revenue and margins
Middleby had $3.2B of revenue in fiscal 2025, up 1.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $559M in fiscal 2025, 17.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Middleby returned $724M to shareholders in fiscal 2025, 129% of free cash flow. The diluted share count fell 3.7%.
Value Middleby yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$2.0B and divides by 52.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Balance sheet
Cash, debt and the ratios that show how comfortably Middleby can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $180M | $162M | $248M | $639M | $222M |
| Debt incl. finance leases | $2.4B | $2.7B | $2.4B | $2.4B | $2.2B |
| Net debt / EBITDA | 3.0x | 3.3x | 2.9x | 2.4x | 2.9x |
| Debt / equity | 1.0x | 1.0x | 0.8x | 0.7x | 0.8x |
| Interest coverage | 11.0x | 7.2x | 5.4x | 6.9x | 6.1x |
| Current ratio | 1.9x | 2.0x | 2.3x | 2.8x | 2.6x |
| Quick ratio | 1.0x | 0.9x | 1.2x | 2.0x | 1.9x |
| Total assets | $6.4B | $6.9B | $6.9B | $7.3B | $6.3B |
| Total liabilities | $3.9B | $4.1B | $3.7B | $3.6B | $3.5B |
| Shareholders' equity | $2.5B | $2.8B | $3.2B | $3.6B | $2.8B |
| Net debt (β = net cash) | $2.2B | $2.6B | $2.2B | $1.8B | $2.0B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$15.1M
2 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Dec 15, 2025 | Edward P GardenDirector | Bought | 14,740 | $146.92 | $2.2M | Form 4 |
| Dec 12, 2025 | Edward P GardenDirector | Bought | 43,838 | $146.53 | $6.4M | Form 4 |
| Dec 11, 2025 | Edward P GardenDirector | Bought | 44,325 | $144.55 | $6.4M | Form 4 |
| Dec 9, 2025 | Robert A NerbonneDirector | Bought | 780 | $128.52 | $0.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 7 / 9 | 4 / 9 |
| Accruals ratio | β3.3% | β3.6% | β13.4% |
| Altman Z'' | 4.47 | 4.93 | 5.27 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Middleby MIDD | $5.1B | 1.6% | 18.0% | 17.5% | 8.7% | β | 4 | |
| Carpenter Technology CRS | $14.2B | 8.6% | 22.5% | 11.6% | 23.7% | 25.1x | 9 | Compare β |
| IDEX IEX | $17.0B | 5.8% | 20.2% | 17.8% | 10.2% | 33.0x | 7 | Compare β |
| ESAB ESAB | $4.1B | 3.7% | 14.5% | 7.5% | 11.0% | 24.1x | 4 | Compare β |
| Nordson NDSN | $17.9B | 3.8% | 25.5% | 23.7% | 11.6% | 32.3x | 5 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.3B | $2.3B | $2.7B | $3.0B | $2.5B | $3.3B | $4.0B | $3.2B | $3.2B | $3.2B |
| Gross profit | $901M | $913M | $1.0B | $1.1B | $882M | $1.2B | $1.4B | $1.3B | $1.3B | $1.3B |
| Research and development | $26.3M | $29.1M | $35.3M | $41.2M | $35.3M | $41.8M | $48.9M | $47.1M | $50.8M | $58.8M |
| Operating income | $419M | $379M | $446M | $514M | $324M | $630M | $640M | $652M | $644M | $575M |
| Interest expense | $23.9M | $26.0M | $58.7M | $82.6M | $78.6M | $57.2M | $89.0M | $121M | $93.4M | $93.8M |
| Pretax income | $421M | $384M | $424M | $463M | $268M | $620M | $564M | $536M | $566M | $482M |
| Income tax | $137M | $85.4M | $106M | $110M | $60.8M | $131M | $128M | $123M | $145M | $115M |
| Net income | $284M | $298M | $317M | $352M | $207M | $489M | $437M | $401M | $428M | β$278M |
| Diluted EPS | $4.98 | $5.26 | $5.70 | $6.33 | $3.76 | $8.62 | $7.95 | $7.41 | $7.90 | β$5.32 |
| Diluted shares | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $294M | $305M | $369M | $377M | $525M | $423M | $333M | $629M | $687M | $630M |
| Capital expenditure | $24.8M | $54.5M | $36.0M | $46.6M | $34.8M | $46.6M | $67.3M | $59.2M | $36.7M | $70.7M |
| Free cash flow | $269M | $250M | $333M | $331M | $490M | $377M | $265M | $570M | $650M | $559M |
| Depreciation and amortization | $58.2M | $69.8M | $97.2M | $103M | $111M | $125M | $138M | $110M | $104M | $105M |
| Stock-based compensation | $27.9M | $6.2M | $2.5M | $8.1M | $19.6M | $42.3M | $58.4M | $45.2M | $31.9M | $13.5M |
| Acquisitions | $211M | $305M | $1.2B | $281M | $79.0M | $964M | $279M | $37.9M | $111M | $32.0M |
| Share buybacks | $4.4M | $240M | $0.0M | $6.1M | $85.9M | $29.3M | $265M | $74.6M | $34.7M | $724M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $4.4M | $240M | $0.0M | $6.1M | $85.9M | $29.3M | $265M | $74.6M | $34.7M | $724M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $68.5M | $89.7M | $71.7M | $94.5M | $268M | $180M | $162M | $248M | $639M | $222M |
| Total debt | $732M | $1.0B | $1.9B | $1.9B | $1.7B | $2.4B | $2.7B | $2.4B | $2.4B | $2.2B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $812M | $932M | $1.1B | $1.2B | $1.3B | $1.7B | $2.0B | $2.0B | $2.3B | $2.7B |
| Current liabilities | $488M | $474M | $559M | $593M | $700M | $915M | $988M | $851M | $829M | $1.1B |
| Inventory | $368M | $425M | $522M | $586M | $540M | $837M | $1.1B | $936M | $656M | $693M |
| Property and equipment, net | $222M | $282M | $315M | $352M | $345M | $381M | $444M | $511M | $385M | $432M |
| Total assets | $2.9B | $3.3B | $4.5B | $5.0B | $5.2B | $6.4B | $6.9B | $6.9B | $7.3B | $6.3B |
| Total liabilities | $1.7B | $2.0B | $2.9B | $3.1B | $5.3B | $3.9B | $4.1B | $3.7B | $3.6B | $3.5B |
| Shareholders' equity | $1.3B | $1.4B | $1.7B | $1.9B | $2.0B | $2.5B | $2.8B | $3.2B | $3.6B | $2.8B |
| Margins | ||||||||||
| Gross margin | 39.7% | 39.1% | 36.9% | 37.3% | 35.1% | 36.8% | 35.9% | 39.6% | 39.7% | 39.1% |
| Operating margin | 18.5% | 16.2% | 16.4% | 17.4% | 12.9% | 19.4% | 15.9% | 20.1% | 20.5% | 18.0% |
| EBITDA margin | 21.0% | 19.2% | 20.0% | 20.9% | 17.3% | 23.2% | 19.3% | 23.5% | 23.8% | 21.3% |
| Net margin | 12.5% | 12.8% | 11.7% | 11.9% | 8.3% | 15.0% | 10.8% | 12.4% | 13.6% | β8.7% |
| FCF margin | 11.9% | 10.7% | 12.2% | 11.2% | 19.5% | 11.6% | 6.6% | 17.6% | 20.6% | 17.5% |
| Returns | ||||||||||
| Return on capital | 14.9% | 13.9% | 11.5% | 10.9% | 9.8% | 16.3% | 9.8% | 9.3% | 8.9% | 8.7% |
| Return on capital employed | 17.9% | 14.3% | 13.0% | 12.2% | 7.3% | 12.6% | 11.3% | 10.9% | 10.3% | 9.8% |
| Return on equity | 23.4% | 22.7% | 21.0% | 19.5% | 10.6% | 21.9% | 16.5% | 13.3% | 12.4% | β8.7% |
| Return on assets | 10.0% | 9.5% | 8.0% | 7.4% | 4.1% | 8.4% | 6.6% | 5.8% | 6.0% | β4.1% |
| Growth | ||||||||||
| Revenue growth | 24.2% | 3.0% | 16.6% | 8.7% | β15.1% | 29.4% | 24.1% | β19.6% | β2.8% | 1.6% |
| Net income growth | 48.3% | 4.9% | 6.4% | 11.1% | β41.2% | 135.7% | β10.6% | β8.2% | 6.9% | β164.8% |
| EPS growth | 48.2% | 5.6% | 8.4% | 11.1% | β40.6% | 129.3% | β7.8% | β6.8% | 6.6% | β167.3% |
| FCF growth | 18.5% | β7.2% | 33.2% | β0.6% | 48.1% | β23.1% | β29.6% | 114.7% | 14.1% | β13.9% |
| Share count change | 0.2% | β0.6% | β2.0% | 0.1% | β0.9% | 2.8% | β3.0% | β1.6% | 0.2% | β3.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.4x | 2.1x | 3.4x | 2.9x | 3.4x | 3.0x | 3.3x | 2.9x | 2.4x | 2.9x |
| Debt / equity | 0.6x | 0.8x | 1.1x | 1.0x | 0.9x | 1.0x | 1.0x | 0.8x | 0.7x | 0.8x |
| Interest coverage | 17.6x | 14.6x | 7.6x | 6.2x | 4.1x | 11.0x | 7.2x | 5.4x | 6.9x | 6.1x |
| Current ratio | 1.7x | 2.0x | 1.9x | 2.0x | 1.8x | 1.9x | 2.0x | 2.3x | 2.8x | 2.6x |
| Quick ratio | 0.9x | 1.1x | 1.0x | 1.1x | 1.0x | 1.0x | 0.9x | 1.2x | 2.0x | 1.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.1% | 2.3% | 1.3% | 1.6% | 1.4% | 1.4% | 1.7% | 1.8% | 1.2% | 2.2% |
| Stock comp / revenue | 1.2% | 0.3% | 0.1% | 0.3% | 0.8% | 1.3% | 1.5% | 1.4% | 1.0% | 0.4% |
| Payouts / FCF | 1.6% | 96.0% | 0.0% | 1.9% | 17.5% | 7.8% | 99.8% | 13.1% | 5.3% | 129.3% |
| Quality scores | ||||||||||
| Piotroski F-score | 7.0 | 5.0 | 5.0 | 6.0 | 5.0 | 6.0 | 6.0 | 7.0 | 7.0 | 4.0 |
| Altman Z'' | 4.1 | 4.0 | 3.4 | 3.7 | 2.7 | 3.7 | 4.0 | 4.5 | 4.9 | 5.3 |
| Accruals ratio | β0.4% | β0.2% | β1.3% | β0.5% | β6.2% | 1.1% | 1.6% | β3.3% | β3.6% | β13.4% |
Source: SEC EDGAR XBRL filings (CIK 0000769520). Data updated October 16, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.